Search hospitals > South Carolina > Gaffney
Gibbs Cancer Center-Gaffney
Claim this profileGaffney, South Carolina 29341
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Ovarian Cancer
Conducts research for Non-Small Cell Lung Cancer
110 reported clinical trials
11 medical researchers
Summary
Gibbs Cancer Center-Gaffney is a medical facility located in Gaffney, South Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Ovarian Cancer, Non-Small Cell Lung Cancer and other specialties. Gibbs Cancer Center-Gaffney is involved with conducting 110 clinical trials across 284 conditions. There are 11 research doctors associated with this hospital, such as Michael Humeniuk, Amarinthia (Amy) Curtis, Vikas Dembla, and Jeremy M. Kilburn.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
Top PIs
Michael HumeniukSpartanburg Medical Center7 years of reported clinical research
Expert in Cancer
Studies Tumors
22 reported clinical trials
40 drugs studied
Amarinthia (Amy) CurtisSpartanburg Medical Center6 years of reported clinical research
Studies Cancer
Studies Breast Cancer
16 reported clinical trials
36 drugs studied
Vikas DemblaSpartanburg Medical Center4 years of reported clinical research
Studies Cancer
Studies Colorectal Cancer
12 reported clinical trials
27 drugs studied
Jeremy M. KilburnGibbs Cancer Center-Pelham2 years of reported clinical research
Studies Tumors
Studies Lung Cancer
7 reported clinical trials
14 drugs studied
Clinical Trials running at Gibbs Cancer Center-Gaffney
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Tumors
Melanoma
Cutaneous Melanoma
Ovarian Tumors
Small Cell Lung Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Online Sexual Health Program
for Breast Cancer Survivors
The goal of this clinical trial is to develop an effective internet-delivered program to help breast cancer survivors manage cancer-related sexual concerns. This study is being done to find out if the study approach is better or worse than the usual approach to helping breast cancer survivors manage cancer-related sexual concerns. The usual approach is defined as care most cancer survivors get for their cancer-related sexual concerns. Participants will complete a questionnaire and if they qualify, they will be assigned to one of sixteen groups of participants. Groups will get access to various kinds of help through an Internet-delivered program called SHINE, which was designed and is run by researchers at the University of Virginia Center for Behavioral Health and Technology. All groups will get access to education about sexual health after cancer: either a standard education website or an enhanced education web program. Groups may also receive up to three additional web programs on: talking to your clinicians about sexual concerns, and/or talking to your partner about sexual concerns, and/or increasing intimacy. Participants are asked to complete the SHINE program within 12 weeks. After participants finish this 12-week period, the study team will ask them to complete a questionnaire to check in with the participant. The participant will be asked one additional time 12 weeks later to complete another questionnaire to see how the participant is doing. A participant will be in the study for 24 weeks.
Recruiting1 award N/A
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Gibbs Cancer Center-Gaffney?
Gibbs Cancer Center-Gaffney is a medical facility located in Gaffney, South Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Ovarian Cancer, Non-Small Cell Lung Cancer and other specialties. Gibbs Cancer Center-Gaffney is involved with conducting 110 clinical trials across 284 conditions. There are 11 research doctors associated with this hospital, such as Michael Humeniuk, Amarinthia (Amy) Curtis, Vikas Dembla, and Jeremy M. Kilburn.